PALISADE BIO, INC. Operating Leases, Rent Expense, Sublease Rentals
PALISADE BIO, INC. (PALI) reported Operating Leases, Rent Expense, Sublease Rentals of $27.10 thousand for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-14.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeasesRentExpenseSubleaseRentals1 · last filed 2019-08-14
- PALISADE BIO, INC. operating leases, rent expense, sublease rentals for the quarter ending 2019-06-30 was -$35.10K.
- PALISADE BIO, INC. operating leases, rent expense, sublease rentals for the quarter ending 2019-03-31 was $62.20K.
| Period end | Operating Leases, Rent Expense, Sublease Rentals 3 month | Operating Leases, Rent Expense, Sublease Rentals 6 month |
|---|---|---|
| 2019-06-30 | -$35.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $27.10K 10-Q · filed 2019-08-14 |
| 2019-03-31 | $62.20K 10-Q · filed 2019-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lexeo Therapeutics, Inc. (LXEO) | United States | $0.278B | -4.19 |
| FATE THERAPEUTICS INC (FATE) | United States | $0.280B | -2.51 |
| Invivyd, Inc. (IVVD) | United States | $0.270B | -2.42 |
| Liminatus Pharma, Inc. (LIMN) | United States | $0.282B | |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| Inhibikase Therapeutics, Inc. (IKT) | United States | $0.296B | -4.44 |
| X4 Pharmaceuticals, Inc (XFOR) | United States | $0.297B | -4.99 |
| SAB Biotherapeutics, Inc. (SABS) | United States | $0.306B | -25.49 |
| Century Therapeutics, Inc. (IPSC) | United States | $0.306B | -4.02 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |